CRIS
Curis Inc
Price:  
3.39 
USD
Volume:  
56,669.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CRIS EV/EBITDA

-2563.3%
Upside

As of 2025-01-14, the EV/EBITDA ratio of Curis Inc (CRIS) is -0.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CRIS's latest enterprise value is 7.86 mil USD. CRIS's TTM EBITDA according to its financial statements is -47.44 mil USD. Dividing these 2 quantities gives us the above CRIS EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 14.6x - 16.2x 15.5x
Forward P/E multiples 14.7x - 19.2x 15.2x
Fair Price (79.64) - (88.04) (83.51)
Upside -2449.3% - -2697.2% -2563.3%
3.39 USD
Stock Price
(83.51) USD
Fair Price

CRIS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-01-03 -0.25
2025-01-02 -0.32
2024-12-31 -0.11
2024-12-30 -0.12
2024-12-27 -0.14
2024-12-26 -0.12
2024-12-24 -0.13
2024-12-23 -0.14
2024-12-20 -0.11
2024-12-19 -0.11
2024-12-18 -0.14
2024-12-17 -0.18
2024-12-16 -0.18
2024-12-13 -0.20
2024-12-12 -0.22
2024-12-11 -0.24
2024-12-10 -0.27
2024-12-09 -0.30
2024-12-06 -0.25
2024-12-05 -0.27
2024-12-04 -0.28
2024-12-03 -0.29
2024-12-02 -0.35
2024-11-29 -0.34
2024-11-27 -0.35
2024-11-26 -0.28
2024-11-25 -0.29
2024-11-22 -0.28
2024-11-21 -0.29
2024-11-20 -0.22
2024-11-19 -0.24
2024-11-18 -0.24
2024-11-15 -0.27
2024-11-14 -0.27
2024-11-13 -0.26
2024-11-12 -0.30
2024-11-11 -0.33
2024-11-08 -0.35
2024-11-07 -0.34
2024-11-06 -0.31
2024-11-05 -0.35
2024-11-04 -0.33
2024-11-01 -0.31
2024-10-31 -0.32
2024-10-30 -0.36
2024-10-29 -0.39
2024-10-28 -0.44
2024-10-25 -0.45
2024-10-24 -0.48
2024-10-23 -0.49